TEVA icon

Teva Pharmaceuticals

28.57 USD
-0.73
2.49%
At close Updated Mar 13, 4:00 PM EDT
Pre-market
After hours
28.58
+0.01
0.04%
1 day
-2.49%
5 days
-6.42%
1 month
-15.92%
3 months
-5.18%
6 months
51.24%
Year to date
-7.69%
1 year
73.57%
5 years
156.23%
10 years
-51.65%
 

About: Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Employees: 32,842

0
Funds holding %
of 8,077 funds
0
Analysts bullish %
of 6 analysts
0
Positive news %
of 17 articles
Price charts implemented using Lightweight Charts™